Bio Path Holdings Inc BPTH:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 04/24/24 EDT
2.49quote price arrow down-0.19 (-7.26%)
Volume
156,712
52 week range
2.49 - 44.80
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.49
  • 52 Week High44.80
  • 52 Week High Date06/23/23
  • 52 Week Low2.49
  • 52 Week Low Date04/24/24

Key Stats

  • Market Cap3.898M
  • Shares Out1.57M
  • 10 Day Average Volume8.78M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-73.11

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.49
  • 52 Week High44.80
  • 52 Week High Date06/23/23
  • 52 Week Low2.49
  • 52 Week Low Date04/24/24
  • Market Cap3.898M
  • Shares Out1.57M
  • 10 Day Average Volume8.78M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-73.11

RATIOS/PROFITABILITY

  • EPS (TTM)-35.76
  • P/E (TTM)-0.07
  • Fwd P/E (NTM)-0.13
  • EBITDA (TTM)-15.761M
  • ROE (TTM)-220.02%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-23,894.59%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bio Path Holdings Inc

 

Profile

MORE
Bio-Path Holdings, Inc. is a biotechnology company. The Company is engaged in developing DNAbilize, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous transfusion. DNAbilize, is a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification that is intended to protect the DNA from destruction by the body’s enzymes when circulating in vivo, incorporated inside of a lipid...
Peter Nielsen
Chairman of the Board, President, Chief Executive Officer, Co-Founder, Chief Financial Officer, Treasurer
Address
4710 BELLAIRE BOULEVARD, SUITE 210
Bellaire, TX
77401
United States

Top Peers

SYMBOLLASTCHG%CHG
HOTH
Hoth Therapeutics Inc
1.17-0.02-1.68%
PCSA
Processa Pharmaceuticals Inc
1.62+0.02+1.25%
ATXI
Avenue Therapeutics Inc
0.0943-0.0397-29.6269%
ARTH
OGEN
Oragenics Inc
1.09UNCHUNCH